top of page

Witching hour for Cinderella stocks

  • apesutto
  • Nov 1, 2018
  • 3 min read





JASON TEH |


We all know the story of Cinderella. Transformed into a glamorous princess, she was the belle at the ball. However, the celebration abruptly stopped at midnight, when her gown turned back into rags and her coach turned into a rotten pumpkin.


Growth stocks are sometimes like Cinderella, glamourous companies that can have their fashionable moments but can also quickly turn into poor investments.


Over the last couple of years, growth has thumped value everywhere. And over the last year, this outperformance was most extreme in Australia.


Figure 1. Annual return of growth and value indices for Australia and the World (as at September 2018)

Source: MSCI


Paying up for high earnings growth is often justified by the fairy tale of strong companies in an environment of scarce earnings growth. However, seasoned investors know that growth and value styles are cyclical. They fall in and out of favour and it would be a mistake to assume one style dominates into perpetuity. Famous examples of growth stock euphoria that eventually reversed includes the ‘Nifty Fifty’ stocks in the 1970s and the technology stocks in the late 1990s / early 2000s.


This mean reversion is especially evident when either style shows extreme outperformance. For example, Australian growth stocks peaked in 2007 and collapsed thereafter. Today, it looks like history is repeating and the clock has just passed the witching hour for Cinderella stocks.


Figure 2. Rolling annual return (MSCI Australia Growth minus Value)

Source: MSCI, Vertium


The reason for this cyclicality is that when share prices are extremely high for either style they provide no margin of safety for any bad news, irrespective of company strength or outlook.


CSL: Australia’s growth bellwether


As a business, CSL is an excellent company because over a long period of time management reinvested aggressively (research and development spend of 10% of revenues with a 45% dividend payout ratio) in a business that generates high return on capital (about 35% ROFE over the last five years).


This has resulted in the company delivering a long runway of rising earnings and a share price to match. With its proven track record and a robust earnings outlook, CSL takes the crown as Australia’s premier growth company.


While CSL’s business case is robust, its current investment case may be on shaky ground.


Growth stocks certainly deserve higher valuation multiples because they deliver greater earnings growth. This is evident over CSL’s history. Over the last seventeen years the variation in its price to earnings (PE) multiple roughly matches the variation in its forecast earnings growth over time. When forecast growth was higher, its PE was higher and vice versa.


Figure 3. CSL’s PE multiple vs its 2-year earnings growth forecast (March 2002 – September 2018)

Source: Factset


However, the relationship between CSL’s valuation multiple and forecast earnings growth has disconnected since early 2017. To make this observation clear the following charts give pause for thought.


Figure 4 shows the history of CSL’s PE multiple at the end of each month between March 2002 and September 2018. For the majority of the 199 monthly observations, CSL traded on a PE multiple of between 20x and 23x. And rarely does it trade above 32x (just 7 out of 199 months).


Figure 4. CSL’s PE multiple history (March 2002 – September 2018)

Source: Factset


Figure 5 shows the number of observations of CSL’s earnings growth forecast at the end of each month between March 2002 and September 2018. Despite CSL’s PE multiple peaking at 37x in August 2018, its forecast earnings growth is at the lower end of its historical range of 10-15% per annum.


Figure 5. CSL’s history of 2-year earnings forecast (March 2002 – September 2018)

Source: Factset


The last time CSL traded more than 30x PE multiple was back in early 2002 when it justifiably matched its two-year earnings growth forecast of greater than 30% per annum. If the fifteen years prior to 2017 is a guide, CSL’s lofty valuation multiple will eventually mean revert to match its earnings growth rate.


Watch out when witching hour approaches


Most so-called Cinderella stocks will turn into ordinary investments. Only a rare few will thrive in the long term but, nevertheless will experience many trials and tribulations along the way.


For example, CSL has seen nasty drawdowns in the past from elevated PEs that can shake out the most patient investors. From 2001 to 2003, its share price lost 76% from peak to trough. It took several years to recover the losses but a decade later the company is one of the most celebrated Australian growth companies.


The challenge for investors is that for every true Cinderella, there are hundreds of wannabes – ugly stepsisters trying to force themselves into your ‘glass slipper’ portfolio.


And if you think you found a true Cinderella, are you able to tell when midnight approaches and valuations reach extremes?


If not… be prepared for large drawdowns and hope your fairy godmother shows up to conjure the happy ever after.

 
 
 

Comentários


DISCLAIMER 

This website and its contents are general in nature and do not constitute or convey personal financial advice. It has been prepared without consideration of anyone’s financial situation, needs, or financial objectives. Before acting on the areas discussed and contained herein, you should consider whether it is appropriate for you and whether you need to seek professional advice. Investment in securities and other financial products involves risk. An investment in a financial product may have the potential for capital growth and income but may also carry the risk that the total return on the investment may be less than the amount contributed directly by the investor. Investors risk losing some or all of their capital invested. Past performance is not a reliable indicator of future performance. The material contained in this website is for information purposes only and is not an offer, solicitation or recommendation with respect to the subscription for, purchase or sale of securities or financial products and neither or anything in it shall form the basis of any contract or commitment. The Company, its related parties and its respective officers may have an interest in the securities or derivatives of any entities referred to in this website. The analyst(s) hereby certify that all the views expressed in this report accurately reflect their personal views about the subject investment theme and/or company securities. Except for any liability which cannot be excluded, the authors of this website accept no liability for any loss or damage suffered by any person as a result of that person, or any other person, placing any reliance on the contents of this website.

Vertium Asset Management Pty Ltd (ABN 25 615 639 659), is a Corporate Authorised Representative (Corporate Authorised Representative Number 001258758) of Clime Asset Management Pty Ltd (ABN 72 098 420 770), AFSL 221146.

The rating issued October 2021 APIR OPS1827AU is published by Lonsec Research Pty Ltd ABN 11 151 658 561 AFSL 421 445 (Lonsec). Ratings are general advice only, and have been prepared without taking account of your objectives, financial situation or needs. Consider your personal circumstances, read the product disclosure statement and seek independent financial advice before investing. The rating is not a recommendation to purchase, sell or hold any product. Past performance information is not indicative of future performance. Ratings are subject to change without notice and Lonsec assumes no obligation to update. Lonsec uses objective criteria and receives a fee from the Fund Manager. Visit lonsec.com.au for ratings information and to access the full report. © 2022 Lonsec. All rights reserved.

The Zenith Investment Partners (ABN 27 103 132 672, AFS Licence 226872) (“Zenith”) rating (assigned APIR OPS1827AU May 2024) referred to in this piece is limited to “General Advice” (s766B Corporations Act 2001) for Wholesale clients only. This advice has been prepared without taking into account the objectives, financial situation or needs of any individual, including target markets of financial products, where applicable, and is subject to change at any time without prior notice. It is not a specific recommendation to purchase, sell or hold the relevant product(s). Investors should seek independent financial advice before making an investment decision and should consider the appropriateness of this advice in light of their own objectives, financial situation and needs. Investors should obtain a copy of, and consider the PDS or offer document before making any decision and refer to the full Zenith Product Assessment available on the Zenith website. Past performance is not an indication of future performance. Zenith usually charges the product issuer, fund manager or related party to conduct Product Assessments. Full details regarding Zenith’s methodology, ratings definitions and regulatory compliance are available on our Product Assessments and at http://www.zenithpartners.com.au/RegulatoryGuidelines

bottom of page